Study Stopped
Loss of interest in the subject
Local Wound Infiltration for Tracheal Reconstruction
Local Wound Infiltration Versus Bilateral Superficial Cervical Plexus Block With Levobupivacaine for Upper Tracheal Resection and Reconstruction Surgery Under General Anesthesia.
1 other identifier
interventional
N/A
0 countries
N/A
Brief Summary
Tracheal resection and reconstruction (TRR) is the treatment of choice for most patients with tracheal stenosis or tracheal tumors .The postintubation tracheal stenosis is the common indication for (TRR).The immediate postoperative period can be anxiety provoking for some reasons such as requirement to maintain a flexed neck, oxygen mask, and surgical pain which inadequately treated. Bilateral superficial cervical plexus block (BSCPB) is a popular regional anesthesia technique for its feasibility and efficacy. The use of regional anesthesia in combination with general anesthesia may lighten the level of general anesthesia required , provide prolonged postoperative analgesia and reduce the requirements for opioid analgesics Local anesthetic infiltration into the surgical incision can relieve pain at the wound site after surgery, as part of multimodal analgesic approach. Levobupivacaine, is "S"-enantiomer of bupivacaine, has strongly emerged as a safer alternative for regional anesthesia than bupivacaine . Levobupivacaine has been found to be equally efficacious as bupivacaine, but with a superior pharmacokinetic profile. Clinically, levobupivacaine has been observed to be well tolerated in regional anesthesia techniques both after bolus administration and continuous post-operative infusion.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Sep 2016
Shorter than P25 for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
October 27, 2016
CompletedFirst Posted
Study publicly available on registry
October 31, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2017
CompletedStudy Completion
Last participant's last visit for all outcomes
May 1, 2017
CompletedSeptember 11, 2020
September 1, 2020
6 months
October 27, 2016
September 9, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
Postoperative pain score
Postoperative pain scores will be assessed using postoperative visual analogue score
For 24 hours after surgery
Secondary Outcomes (9)
Systolic blood pressure
For 4 hours after start of surgery
Diastolic blood pressure
For 4 hours after start of surgery
Heart rate
For 4 hours after start of surgery
Peripheral oxygen saturation
For 4 hours after start of surgery
End-tidal Carbon dioxide tension
For 4 hours after start of surgery
- +4 more secondary outcomes
Study Arms (2)
Superficial cervical plexus block
EXPERIMENTALPatients will receive bilateral superficial cervical plexus block using levobupivacaine
Local wound infiltration
ACTIVE COMPARATORPatients will receive local wound infiltration with levobupivacaine after the conclusion of surgery
Interventions
Patients will receive bilateral superficial cervical plexus block
Patients will receive local wound infiltration
Eligibility Criteria
You may qualify if:
- American Society of Anesthesiologists physical class status I or II
- Undergoing elective upper tracheal resection and reconstruction surgery
You may not qualify if:
- Age less than18 years
- Patients with preoperative medication included opioid
- History of allergy to the drugs used
- Coagulation disorders
- Pregnancy
- Patient refusal
- Local sepsis
- Inability to understand the study protocol or pain scale.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Officials
- STUDY CHAIR
Hanaa M Elbendary, MD
Department of Anaesthesia, Surgical Intensive Care and Pain Medicine, College of Medicine, Mansoura University, Mansoura, Egypt
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 27, 2016
First Posted
October 31, 2016
Study Start
September 1, 2016
Primary Completion
March 1, 2017
Study Completion
May 1, 2017
Last Updated
September 11, 2020
Record last verified: 2020-09